How many studies have been conducted on Receptor Par 1?

BiohacksAI has indexed 300 PubMed studies on Receptor Par 1, including 2 randomized controlled trials (RCTs). 27% of studies involve human subjects.

What are the main research areas for Receptor Par 1?

The primary research domains for Receptor Par 1 are 🔬 Oncology, 🦴 Bone & Joint, ❤️ Cardiovascular. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Receptor Par 1

A thrombin receptor subtype that couples to HETEROTRIMERIC GTP-BINDING PROTEINS resulting in the activation of a variety of signaling mechanisms including decreased intracellular CYCLIC AMP, increased TYPE C PHOSPHOLIPASES and increased PHOSPHOLIPASE A2.

300+ PubMed studies analyzed · 2 RCTs · Evidence Score: 46.4

Research Domains

Receptor Par 1 has been studied across 19 research domains including 🔬 Oncology, 🦴 Bone & Joint, ❤️ Cardiovascular, 🔬 Inflammation, ✨ Skin & Hair. The primary research focus is 🔬 Oncology with 22% of studies addressing this area.

Loading evidence profile...

This evidence profile for Receptor Par 1 is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.